Phase I dose-escalating trial of leukotuximab in South Korea

Trial Profile

Phase I dose-escalating trial of leukotuximab in South Korea

Recruiting
Phase of Trial: Phase I

Latest Information Update: 06 Oct 2014

At a glance

  • Drugs Leukotuximab (Primary)
  • Indications Acute myeloid leukaemia
  • Focus Adverse reactions
  • Sponsors 3SBio
  • Most Recent Events

    • 06 Oct 2014 New trial record
    • 07 Aug 2014 This trial was initiated in June 2014 and is expected to be completed in late 2015, according to a 3SBio media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top